Medical Devices: Page 59
-
Courtesy of Thermo Fisher Scientific
Thermo Fisher reports 9% drop in Q1 revenue, shares slip
The drop in revenue accompanied a 41% decline in net income, with Life Sciences Solutions and Specialty Diagnostics revenue declining by double digits.
By Peter Green • April 26, 2023 -
Permission granted by Insulet
Insulet gets FDA clearance for tubeless pump to eliminate daily shots for basal insulin users
The device, called Omnipod GO, eliminates the need for daily injections for people with Type 2 diabetes, CEO Jim Hollingshead said.
By Elise Reuter • April 25, 2023 -
Explore the Trendline➔
Sara Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Courtesy of GE Healthcare
GE HealthCare revenue up in first quarter as a standalone company, but shares drop
Steady demand and supply chain improvements have helped it grow the business, even as inflation and foreign exchange rates pressure its income.
By Elise Reuter • Updated April 25, 2023 -
FatCamera via Getty Images
Know Labs hopes to advance non-invasive glucose sensor with proof-of-concept test
The company wants to use its Bio-RFID technology for glucose monitoring, and recently showed the device could detect and quantify specific molecules in water.
By Nick Paul Taylor • April 25, 2023 -
Philips says revenue rises 6%, sees €575M in recall-related legal costs
CEO Roy Jakobs expressed confidence in the company’s outlook for the year ahead and said setting aside the funds to resolve a U.S. class action lawsuit was “an important step.”
By Susan Kelly • April 24, 2023 -
ipopba / iStock
Graphene ‘tattoo’ pacemaker senses and treats irregular heart beats in rats
While still in early stages of development, the tattoo material can mold to the heart, unlike the more rigid implanted pacemakers used today, reducing some of the problems with traditional and leadless technologies.
By Nick Paul Taylor • April 24, 2023 -
Courtesy of Medtronic
Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump
Analysts called the FDA approval a “positive” for Medtronic that “should somewhat aid in a turnaround of its U.S. diabetes franchise.”
By Nick Paul Taylor • April 24, 2023 -
Zhanna Hapanovich via Getty Images
Alphatec buys robotic spine navigation system for $55M
The spine surgery specialist expects the robotic platform to begin generating revenue in 2025.
By Susan Kelly • Updated April 21, 2023 -
Sasirin Pamai via Getty Images
Lawsuit accuses J&J subsidiary of selling faulty knee replacements
A patient who had DePuy’s Attune knee system implanted, and then replaced when it loosened, claims the company downplayed the risks of the device.
By Elise Reuter • Updated April 21, 2023 -
Permission granted by Abbott
Q&AFriday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market
Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.
By Susan Kelly • April 21, 2023 -
Andrii Yalanskyi via Getty Images
Report names connected medical devices with the biggest cybersecurity risks
The findings come as medical device makers face upcoming FDA requirements for providing cybersecurity information as part of their pre-market submissions.
By Nick Paul Taylor • April 21, 2023 -
Courtesy of Nevro
Nevro names Hologic exec as CEO
Kevin Thornal will take the reins from current CEO D. Keith Grossman, who will retire next week.
By Elise Reuter • April 20, 2023 -
Courtesy of Abbott Laboratories
Abbott hit with FDA warning letter over unapproved changes to heart disease test
The FDA said that four changes made to the tests “could significantly affect the safety or effectiveness of the devices.”
By Nick Paul Taylor • Updated April 20, 2023 -
Courtesy of Fresenius
Fresenius flags fault with infusion system acquired last year in $240M deal
Fresenius noted a problem with the devices that can cause loss of power, potentially delaying or interrupting the supply of critical fluids and medications.
By Nick Paul Taylor • April 20, 2023 -
Permission granted by Johnson & Johnson
J&J study data show dramatic benefit to multiple myeloma cell therapy
A study abstract inadvertently posted online showed J&J and Legend’s therapy, Carvykti, reduced the risk of disease progression or death by more than 70% over standard drugs.
By Ned Pagliarulo • April 19, 2023 -
Medtronic says it plans more layoffs, declines to specify locations
The company said it began notifying some employees on Tuesday, but would not confirm the number of positions or locations of the jobs that would be cut.
By Elise Reuter • April 19, 2023 -
Permission granted by Abbott
Abbott boosts organic sales outlook as device demand accelerates
A rebound in surgical procedure volumes as hospital staffing improved at the start of the year partially offset a steep drop in COVID-19 testing sales.
By Susan Kelly • April 19, 2023 -
Stock via Getty Images
AFib study shows no effect on outcomes from 1-year delay of catheter ablation
Early treatment could be a boon for medtech companies such as Boston Scientific and Medtronic but is potentially challenging for healthcare systems. The new study suggests waits of up to a year will not harm patients.
By Nick Paul Taylor • April 19, 2023 -
VCG / Stringer via Getty Images
Intuitive posted 26% jump in robotic procedures in Q1 as hospitals chipped away at backlog
The company experienced “some backlog effect from patients generally returning to more normalized healthcare routines, given the effect of the pandemic over several years.”
By Nick Paul Taylor • April 19, 2023 -
Permission granted by Johnson & Johnson
J&J raises forecast as medtech procedures recover
The company’s medical device business grew by more than 7% in the first quarter.
By Elise Reuter • April 18, 2023 -
Sarah Silbiger via Getty Images
Post-approval modification of high-risk devices linked to 30% jump in recall risk: study
The authors suggest improved post-marketing surveillance systems may be needed to mitigate risks to patient safety.
By Nick Paul Taylor • April 18, 2023 -
Permission granted by Medtronic
What medtech startups need to know about remote monitoring
Four medtech executives talked about the future of hospital at home, and the difference between consumer devices and medical devices, in an event hosted by the Colorado Bioscience Association.
By Elise Reuter • April 17, 2023 -
Courtesy of LivaNova
LivaNova CEO quits as firm announces higher-than-expected preliminary earnings
Analysts from Needham and Stifel had opposite takes on how McDonald’s departure will affect the company, which has struggled in recent years to bring new products to market.
By Peter Green • April 17, 2023 -
Permission granted by Abbott
Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage
With a standalone reader, Abbott said it is working to make the FreeStyle Libre 3 system available to people covered by Medicare.
By Elise Reuter • April 17, 2023 -
Shutterstock/Lukasz Pawel Szczepanski
Sponsored by EsperOvercome the top 5 device management challenges of remote patient care with ease
As more organizations adopt RPM, they’re facing increasingly complex challenges managing, updating and securing their devices.
April 17, 2023
Previous
